Julie Doan

Suggest Changes
Learn More
BACKGROUND Polypharmacy increases the risk of cytochrome P450-based drug-drug interactions (CYP450-DDIs), leading to decreased therapeutic efficacy or increased drug toxicity. OBJECTIVE The aims of(More)
  • 1